What class of medication is commonly used to manage hyperlipidemia in nephrotic syndrome?

• A. Fibrates
• B. Bile acid sequestrants
• C. Niacin
• D. Statins

Answer: (D)

In nephrotic syndrome, the lipid problem comes mainly from the liver making more lipoproteins in response to hypoalbuminemia. The most effective way to address this is with statins. They inhibit HMG-CoA reductase in the liver, lowering cholesterol synthesis and upregulating LDL receptors, which increases clearance of LDL from the blood. This leads to a meaningful drop in LDL cholesterol and reduces cardiovascular risk, which is the main goal in these patients.

Other options mainly target different parts of the lipid profile or have more safety concerns in kidney disease. Fibrates mainly reduce triglycerides and raise HDL, and are not as helpful when the dominant issue is elevated LDL cholesterol. Niacin can alter VLDL and HDL but has tolerability issues and limited added benefit. Bile acid sequestrants lower LDL but are often less effective, can cause GI side effects, and may interfere with absorption of other drugs and fat-soluble vitamins. So, statins are the first-line choice for managing nephrotic-syndrome–related hyperlipidemia.